Colab Platforms (542866)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 95.91% shows the business is expanding its top line rapidly.
• ROE of 21.36% and ROCE of 16.59% point to decent capital efficiency on a small equity base.
• Piotroski F-Score of 7/9 indicates reasonable financial health across profitability, leverage, and efficiency metrics.
• Latest quarter sales of ₹46 Cr give the company meaningful scale relative to its ₹159 Cr market cap.

Concerns

• P/E of 737 and PEG of 12.65 imply an extreme valuation with almost no room for error.
• Latest quarter net profit of only ₹1 Cr on ₹46 Cr sales is a razor-thin 2.2% net margin.
• Profit growth of 20.65% trails sales growth of 95.91%, suggesting margin compression or lower-quality earnings.
• Price of ₹15.54 sits far below the stated 52-week range of ₹67.86-₹204.60, reflecting a severe de-rating; internal data inconsistencies also reduce trust.

AI Analysis

Let me start with what I don't understand. A stock at ₹15.54, with a book value of ₹1.12 and a P/E of 737, means the market is asking me to pay 13.87 times net worth for every rupee of assets. Graham's first rule is margin of safety; at this price, there is none. The latest quarter reports sales of ₹46 crore but net profit of only ₹1 crore — a razor-thin 2.2% margin. That is not a franchise with pricing power. Sales growth of 95.91% catches the eye, but profit growth is just 20.65%, and the PEG ratio of 12.65 means I am paying more than twelve times the growth rate. That is speculation, not investment. The P/E of 737 implies annual earnings of under ₹1 crore, yet the latest quarter alone shows ₹1 crore. When the numbers don't tie, I become cautious. Yes, ROE of 21.36% and ROCE of 16.59% look decent, and a Piotroski F-Score of 7/9 suggests the financials aren't rotten. But these figures rest on a very small equity base, and one good quarter can distort. I don't see a durable moat; in financial services, capital tends to be a commodity and competition erodes excess returns. The dividend yield is 0.01%, so I am not paid to wait. The price is far below the stated 52-week range of ₹67.86 to ₹204.60; when a stock falls that hard, the market is telling me something. With a ₹159 crore market cap and such thin earnings, the company must compound at extraordinary rates for years to justify this price. That is a high-wire act. I would rather miss this opportunity than overpay for hope.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer